# LanzaTech Global, Inc. > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/fi/companies/LanzaTech Global, Inc.). ## Overview LanzaTech Global, Inc. develops and commercializes gas fermentation technology that converts waste carbon streams into ethanol and other products. The company primarily monetizes its platform through technology licensing and royalties, while also expanding into project ownership, operatorship, and research and development services for fuels and chemicals. ## Products & services • Gas fermentation technology licensing • Royalty-based commercialization agreements • Microbes and media sales • R&D services for biocatalysts and novel technologies • Sustainable aviation fuel and renewable diesel solution (CirculAir™) • Biorefining project development and operatorship - **Technology licensing and royalties** (45%) — Licenses for customers to build, own, and operate facilities using LanzaTech's process, with royalties tied to revenue generated. - **One-time project and commercialization revenue** (35%) — Non-recurring revenue from project services, engineering, equipment-related work, and other commercialization activities. - **Microbes and media** (10%) — Sales of proprietary microbes and media used in fermentation and process deployment. - **Research and development services** (5%) — Contract R&D and biocatalyst development services for fuels and chemicals applications. - **Joint venture and platform offerings** (5%) — Joint offerings such as CirculAir™ that combine LanzaTech technology with partner platforms for SAF and renewable diesel. - Gas fermentation technology licensing - Royalty-based commercialization agreements - Microbes and media sales - R&D services for biocatalysts and novel technologies - CirculAir™ sustainable aviation fuel solution - Biorefining project development and operatorship ## Customers LanzaTech sells mainly to industrial customers, project developers, and strategic partners that want to convert waste carbon into fuels and chemicals. Its licensing model serves operators that build and run plants themselves, while its newer cohort-based model also targets partners needing development support, financing coordination, and eventual product access. The company also works with joint venture partners and government-supported projects, especially where public funding helps de-risk first-of-a-kind deployments. - **Industrial plant operators** (primary) — Customers that build, own, and operate facilities using LanzaTech's technology and pay royalties on output or revenue. - **Project development partners** (primary) — Partners that buy project services, engineering, and commercialization support to move plants from concept to operation. - **Strategic fuel and chemical partners** (secondary) — Companies pursuing sustainable aviation fuel, renewable diesel, and chemical production using waste feedstocks. - **Joint venture and co-owned facilities** (secondary) — Partners in commercial plants such as the Shougang LanzaTech venture and other international deployments. - **Government-backed project sponsors** (secondary) — Customers or counterparties whose projects depend on DOE grants, cooperative agreements, or loan guarantees. - Industrial operators that license the technology and run plants - Project developers needing engineering and commercialization support - Strategic partners in fuels, chemicals, and sustainable aviation fuel - Joint venture partners that co-develop and operate facilities - Government-supported projects that rely on grants or loan guarantees ## Geography LanzaTech is headquartered in the United States but its commercial footprint is international, with operating plants and development projects in China, India, Belgium, and other countries. The company’s near-term execution is tied to project financing and government support in the U.S., while its installed base and partnership network create exposure to Asia and Europe. Geography matters because plant deployment, permitting, and funding timelines differ materially by country and can affect when revenue is recognized. - **United States** (40%) — Estimated from headquarters, financing, and DOE-linked project exposure. - **Asia** (40%) — Estimated from commercial plants in China and India and broader project pipeline. - **Europe** (20%) — Estimated from the commercial plant in Belgium and European development activity. - United States headquarters and key financing/risk exposure - China commercial base through the Shougang LanzaTech joint venture - India and Belgium host additional commercial plants - Other projects are in development across multiple countries - Government-dependent U.S. projects can delay revenue timing ## Strategy LanzaTech is shifting from one-off project execution toward a cohort-based commercialization model that sequences projects by maturity, financing readiness, and offtake progress. Management is also trying to preserve liquidity, reduce spending, and diversify project funding so the platform can scale with less dependence on any single government program or customer. The longer-term goal is to build more recurring revenue from licensing, product sales, and potential carbon credits as projects move into operation. - **Cohort-based commercialization** (short-term) — Improves execution discipline and creates a staged path from services to recurring revenue. - **Liquidity preservation and cost control** (short-term) — The company remains loss-making and needs cash runway to fund development. - **Funding diversification** (medium-term) — Reduces dependence on DOE-linked milestones and lowers project timing risk. - **Expand control in the biorefining value chain** (medium-term) — Ownership and operatorship can improve product access and economics versus pure licensing. - Move from one-off projects to a portfolio/cohort model - Sequence projects by financing, offtake, and regulatory readiness - Preserve liquidity through expense optimization - Diversify funding away from sole reliance on DOE support - Expand from licensing into ownership and operatorship - Build recurring revenue from products and carbon credits ## Risks LanzaTech’s business is exposed to project-financing risk, customer adoption risk, and execution risk because commercialization depends on third-party plant builds and milestone-based deployments. A prolonged U.S. government shutdown is a specific near-term risk because DOE-related grants, loan guarantees, and cost-share projects can delay revenue recognition and working capital inflows. The company is also still loss-making, so any delay in project conversion or funding can pressure liquidity and extend the path to profitability. - **U.S. government shutdown / DOE funding delays** [high] — Many projects depend directly or indirectly on DOE grants, cooperative agreements, or loan guarantees. - **Project financing and offtake risk** [high] — Revenue depends on projects reaching financing close and securing customer offtake before deployment. - **Liquidity and going-concern pressure** [high] — The company has not achieved operating profitability and continues to fund losses with external capital. - **Execution risk in first-of-a-kind deployments** [medium] — Gas fermentation plants require technical, regulatory, and partner coordination across jurisdictions. - DOE and government shutdown delays can push out project milestones - Project financing bottlenecks can delay licensing and equipment revenue - Losses and cash burn create ongoing liquidity pressure - Commercialization depends on third-party plant buildouts and offtake - International deployment adds regulatory and execution complexity ## Accounting Revenue recognition is judgmental because the company earns a mix of licensing royalties, one-time project revenue, and recurring revenue from microbes and media, each with different timing. Investors should also watch estimates around fair value measurements, debt-related instruments, and stock-based compensation because these can materially affect reported losses and balance-sheet values. Quarterly results can be volatile as project milestones, financing events, and government-related approvals shift the timing of revenue and costs. - **Revenue recognition across licensing, royalties, and project services** — Can shift reported revenue between recurring and one-time categories - **Fair value measurement of Brookfield-related instruments** — Can materially affect other income/expense and net loss - **Stock-based compensation and warrant/SAFE valuation** — Affects operating expenses and reported earnings volatility - **Going-concern and liquidity assumptions** — May influence disclosures, estimates, and financing classification - Mixed revenue streams create different recognition timing - One-time project revenue can shift with milestone completion - Royalty and licensing revenue depends on customer plant output - Fair value estimates affect debt and warrant-related items - Stock-based compensation and financing instruments can swing losses --- *Last updated: 2026-04-28T20:22:19.950113+00:00*